Navigation Links
Innovative smallpox vaccine research study to be conducted at Case Medical Center

University Hospitals Case Medical Center (UHCMC) and Case Western Reserve University School of Medicine are part of a nationwide research study to determine the safety and effectiveness of a new smallpox vaccine geared toward adults ages 18 to 34 who have never been vaccinated against the disease. The study is the first of its type in Northeast Ohio.

The current FDA-approved vaccine, Dryvax®, is not recommended for use on everyone because of the potential for serious side effects in certain individuals. “For example, the current vaccine cannot be used in immune-compromised individuals, such as patients with HIV or individuals with certain skin conditions such as eczema,” says Robert A. Salata, M.D., chief of the Division of Infectious Diseases at Case Western Reserve University School of Medicine and UHCMC.

The new vaccine, IMVAMUNE®, is different from Dryvax® in that it contains a more weakened form of the live-virus within the vaccine.

“Because the vaccine is weakened, the side effects should be minimized enough to give the vaccine to all individuals, even those whose immune systems are suppressed,” says Dr. Salata. “Our hope is that the new vaccine will be a safer alternative to the current vaccine.”

UHCMC and the School of Medicine will act as a subunit of St. Louis University’s Center for Vaccine Development, which is one of seven national testing sites known as Vaccine and Treatment Evaluation Units (VTEUs), designated by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

The research study, which is actively recruiting and begins here June 15, will follow 215 volunteers nationwide over a two-year period. Volunteers must be in general good health and must not have previously been vaccinated against smallpox.

Smallpox is a contagious and sometimes fatal infectious disease characterized by raised bumps that appear on the face and body of an
'"/>

Source:Case Western Reserve University


Page: 1 2

Related biology news :

1. Innovative collaboration brings Arctic science into the classroom
2. Innovative coating could give medical implants a longer life
3. Innovative method for creating a human cytomegalovirus vaccine outlined
4. Innovative movies show real-time immune-cell activity within tumors
5. Stopping smallpox in its tracks: A new anti-viral approach
6. Secret of smallpoxs success may lead to bioterror cure
7. LIAI scientists make major finding on potential smallpox treatment
8. Researchers develop new testing methods for potential monkeypox or smallpox outbreak
9. Serious adverse reactions to smallpox vaccine appear to be limited
10. Mice studies illustrate potential of chimp/human antibodies to protect against smallpox
11. Defective immune system response to smallpox vaccine detailed in new study

Post Your Comments:
(Date:11/23/2009)...earch presents strong evidence that the "synergist...traffic-related pollution and indoor endotoxin cau...other exposure alone. , Environmental health s...lege of Medicine have shown that children exposed ...nd indoor endotoxin during early life are six time...
(Date:11/23/2009)...er 23, 2009 - The time of day matters to forest tr... produced by a research team led by Professor Malc...vice-principal for research and colleagues in the ...George campus. , Capitalizing on their previou...e research team examined how poplar trees use thei...
(Date:11/23/2009)...urrent research suggests that a common oral bacter...d report by Nichols et al, "Unique Lipids from a C...2 Ligands Capable of Enhancing Autoimmunity," appe...urnal of Pathology . , Multiple sclerosis (MS), ...n and spinal cord, affects nearly 1 in 700 people ...
Breaking Biology News(10 mins):Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2Time of day matters to thirsty trees, U of T researcher discovers 2Factors from common human bacteria may trigger multiple sclerosis 2Patients with moderate to severe periodontitis need evaluation for heart disease risk 50398 1Patients with moderate to severe periodontitis need evaluation for heart disease risk 50398 2A thirst for blood sparks toxic algal blooms 9065 1A thirst for blood sparks toxic algal blooms 9065 2Single thawed embryo transfer after PGD does not affect pregnancy rates 9062 1Single thawed embryo transfer after PGD does not affect pregnancy rates 9062 2Single thawed embryo transfer after PGD does not affect pregnancy rates 9062 3
...out a half a liter of rumen fluid - fermented, liq...chamber of a cow,s stomach - produced about 600 mi...tage needed to run one rechargeable AA-sized batte...ociate professor of food, agricultural and biologi...rumen fluid itself won,t be used as an energy sour...
...ut helter-skelter forming new connections, only a ...oses which connections to keep and which to prune ... the most electrical activity—a finding that could... development. , The work, published in the April 2...rough zebrafish. Stephen Smith, PhD, professor of ...
Camera Traps Reveal Rare Asiatic Cheetahs
Other Biology News:It's electric: Cows show promise as powerplants 2It's electric: Cows show promise as powerplants 3Speak up: Louder neurons form more connections 2
(Date:11/24/2009)...swire-FirstCall/--CellTherapeutics,Inc.(CTI)(Nasda...iperJaffrayHealthCareConference.Theconferencewillb..., CTIwillpresentonTuesday,December1at11:00a.m.Eas...,spresentationwillbeavailableat www.celltherapeuti...s. , ,PiperJaffrayHealthCareConference,NewYorkPal...
(Date:11/23/2009)... ultra-fast communication, computation and more po...trying to use quantum states as carriers of inform...hysicists have shown, mathematically, how to gentl...n, while keeping the information intact. Their wor...view Letters and highlighted with a Viewpoint in ...
(Date:11/23/2009)...3/PRNewswire-FirstCall/-YMBioSciencesInc.(NYSEAmex...anythatidentifiesandadvancesadiverseportfolioofpro...opment,todayreportedthatCytopia(ASX:CYT)hascommenc...ent,orally-administeredJAK1/JAK2inhibitor.Thetrial...AproposaltomergeCytopiaintoYMhasbeenpreviouslyanno...
(Date:11/23/2009)...swire/--ImmuneDesignC or p.(IDC)announcedtodaythat...Dr.Carterhasasuccessfultrackrec or dinbiotechnolog...eOfficeratZymoGenetics,inSeattle,WAandChiefScienti..., (Photo: http://www.newscom.com/cgi-bin/prnh/2009...ChiefExecutiveOfficercommented,"Iamdelightedtowelc...
Breaking Biology Technology:YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 2YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 3YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 4Immune Design Corp. Announces Appointment of Dr. Bruce L.A. Carter as Executive Chairman and Director 2
...from attending the 2nd Annual Future of Work Worl...people from business, government and community eco...ture workplace and develop action plans to make it...ndependence Mall area of Philadelphia where the co...e old, the restored and the new. This part of the ...
... written, said, and even adjudicated about peer-to...yet another music service promising to legitimize ...nd it,s been far-from-ignored by the 1.5 million p...uiet debut about nine months ago. In that short ti...al Modulation has transformed from a legal music ...
Norlight to expand fiber network into central Illinois
Other Biology Technology:The future of work is now 2The future of work is now 3The future of work is now 4Mercora gets music sharing right 2Mercora gets music sharing right 3
UCB MoDC Cell Chip-IHC from 3H Biomedical AB
UCB EPC Cell Chip-IHC from 3H Biomedical AB
UCB Monocyte Cell Chip-IHC from 3H Biomedical AB
Basophil Chip-IHC from 3H Biomedical AB
Biology Products: